Abstract:Mai Zhang, 1 Yan Li, 1, 2 Chunli Han, 3 Shiying Chu, 1 Peng Yu, 1 Wenbo Cheng 1, 2 1 Mass Spectrometry Application Center, Tianjin Guoke Medical Technology Development Co., Ltd, Tianjin, People's Republic of China; 2 Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences (CAS), Suzhou, People's Republic of China; 3 Mass Spectrometry Application Center, Shandong CAS Intelligent Manufacturing Medical Device Technology Co., Ltd, Zaozhuang, People's Republic of China Correspondence: Wenbo Cheng, Email Background: Inhibition of amyloid β protein fragment (Aβ) aggregation is considered to be one of the most effective strategies for the treatment of Alzheimer's disease. (-)-Epigallocatechin-3-gallate (EGCG) has been found to be effective in this regard; however, owing to its low bioavailability, nanodelivery is recommended for practical applications. Compared to chemical reduction methods, biosynthesis avoids possible biotoxicity and cumbersome preparation processes. Materials and Methods: The interaction between EGCG and Aβ 42 was simulated by molecular docking, and green tea-conjugated gold nanoparticles (GT-Au NPs) and EGCG-Au NPs were synthesized using EGCG-enriched green tea and EGCG solutions, respectively. Surface active molecules of the particles were identified and analyzed using various liquid chromatography-tandem triple quadrupole mass spectrometry methods. ThT fluorescence assay, circular dichroism, and TEM were used to investigate the effect of synthesized particles on the inhibition of Aβ 42 aggregation. Results: EGCG as well as apigenin, quercetin, baicalin, and glutathione were identified as capping ligands stabilized on the surface of GT-Au NPs. They more or less inhibited Aβ 42 aggregation or promoted fibril disaggregation, with EGCG being the most effective, which bound to Aβ 42 through hydrogen bonding, hydrophobic interactions, etc. resulting in 39.86% and 88.50% inhibition of aggregation and disaggregation effects, respectively. EGCG-Au NPs were not as effective as free EGCG, whereas multiple thiols and polyphenols in green tea accelerated and optimized heavy metal detoxification. The synthesized GT-Au NPs conferred the efficacy of diverse ligands to the particles, with inhibition of aggregation and disaggregation effects of 54.69% and 88.75%, respectively, while increasing the yield, enhancing water solubility, and decreasing cost. Conclusion: Biosynthesis of nanoparticles using green tea is a promising simple and economical drug-carrying approach to confer multiple pharmacophore molecules to Au NPs. This could be used to design new drug candidates to treat Alzheimer's disease. Keywords: gold nanoparticles, green synthesis, (-)-epigallocatechin-3-gallate, liquid chromatography tandem triple quadrupole mass spectrometry, amyloid β protein, green tea Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive progression. The Alzheimer's Disease International (ADI) 2018 Global Report stated that every three seconds, someone in the world will develop dementia. 1 Currently, the pathogenesis of AD is highly controversial, but the main pathological hallmark is the misfolding of extracellular amyloid β-protein (Aβ) and neurofibrillary tangles induced by intracellular tau proteins. 2,3 Consequently, inhibition of Aβ aggregation is considered to be one of the most effective strategies for the treatment of AD. A variety of chemicals, including peptides, 4 curcumin, 5 alginate, 6 resveratrol, 7 and quercetin, 8 have been shown to inhibit Aβ fibrillation. Therein, (-)-epigallocatechin-3-gallate (EGCG), one of the most effective substances for inhibiting Aβ aggregation and promoting mature fiber disaggregation, 9–12 was achieved through the interaction of its own phenolic ring with the aromatic residues of Aβ by hydrogen bonding, aromatic stacking, and hydrophobicity. 13,14 Furthermore, in addition to chelating metal ions and scavenging free radicals, 15–17 Seidler et al revealed that EGCG could disaggregate brain-derived tau fibrils in vitro, fully validating the wide array of therapeutic potential of EGCG. 18 However, the applicability of EGCG in humans has encountered with rather limited success largely due to its low stability, poor blood–brain barrier (BBB) permeability, and rapid metabolic clearance, 19 ultimately resulting in an absolute bioavailability of only 0.1%. 20 Accordingly, diversified forms of EGCG delivery systems have been designed in the clinical setup. 21–25 Istenič et al utilized liposomes to -Abstract Truncated-

Epigallocatechin-3-gallate (Egcg)-Stabilized Selenium Nanoparticles Coated with Tet-1 Peptide to Reduce Amyloid-β Aggregation and Cytotoxicity

Quercetin-loaded Selenium Nanoparticles Inhibit Amyloid-Β Aggregation and Exhibit Antioxidant Activity

Biogenic Selenium Nanoparticles Attenuate Aβ25–35-Induced Toxicity in PC12 Cells via Akt/CREB/BDNF Signaling Pathway

Biogenic Selenium Nanoparticles Attenuate Aβ 25–35 -Induced Toxicity in PC12 Cells via Akt/CREB/BDNF Signaling Pathway

Dual-functional selenium nanoparticles bind to and inhibit amyloid β fiber formation in Alzheimer's disease

A Novel Synthesis of Selenium Nanoparticles Encapsulated PLGA Nanospheres with Curcumin Molecules for the Inhibition of Amyloid Β Aggregation in Alzheimer's Disease

C3N Nanodots Inhibits Aβ Peptides Aggregation Pathogenic Path in Alzheimer's Disease.

Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer’s Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation

Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer’s Disease

Selenium-core Nanozymes Dynamically Regulates Aβ & Neuroinflammation Circulation: Augmenting Repair of Nervous Damage

Selenium and Zinc against Aβ 25–35 -Induced Cytotoxicity and Tau Phosphorylation in PC12 Cells and Inhibits γ-cleavage of APP

Facile synthesis of EGCG modified Au nanoparticles and their inhibitory effects on amyloid protein aggregation

Selenium-Doped 3D Porous Molybdenum Carbide Nanospheres Improve Mitochondrial Function by Reducing Oxidative Stress in Alzheimer’s Disease

Biosynthesis of Nanoparticles with Green Tea for Inhibition of β-Amyloid Fibrillation Coupled with Ligands Analysis

Synergistic Effects of Negatively Charged Hydrophobic Nanoparticles and (−)-Epigallocatechin-3-gallate on Inhibiting Amyloid Β-Protein Aggregation

Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid- β aggregation and inhibiting fungal infection

Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer’s disease

Inhibition of Aβ Aggregates in Alzheimer’s Disease by Epigallocatechin and Epicatechin-3-gallate from Green Tea

Serum albumin-embedding copper nanoclusters inhibit Alzheimer's β-amyloid fibrillogenesis and neuroinflammation

Blood brain barrier-targeted delivery of double selenium nanospheres ameliorates neural ferroptosis in Alzheimer's disease

Rational Design of Dual-Functionalized Gd@C82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer's Disease Via Inhibition of Aβ Aggregation.